Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Colorectal Cancer
2		Additional conditions recognized in this trial
			Adenocarcinoma
			Colorectal Neoplasms
3		More general conditions related to this trial
			Carcinoma
			Colonic Diseases
			Digestive System Diseases
			Digestive System Neoplasms
			Gastrointestinal Diseases
			Gastrointestinal Neoplasms
			Intestinal Diseases
			Intestinal Neoplasms
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Glandular and Epithelial
			Rectal Diseases
4		Interventions listed in this trial
			BCG vaccine
			alum adjuvant
5		Additional drug interventions recognized in this trial
			Aluminum sulfate
			Antibodies
			Antibodies, Monoclonal
6		More general drug interventions related to this trial
			Adjuvants, Immunologic
			Immunologic Factors
			Pharmacologic Actions
			Physiological Effects of Drugs
7		Sponsors listed in this trial
			Onyvax Limited at St. George's Hospital Medical School